12 employees
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
2020
$41M
from 2 investors over 2 rounds
BlueJay Therapeutics raised $41M on August 16, 2022
Investors: Octagon Capital Advisors and RiverVest Venture Partners